Cargando…
Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma
BACKGROUND: Osteosarcoma is a rare form of cancer but with a substantial need for new active drugs. There is a particular need for targeted therapies to combat metastatic disease. One possible approach is to use an antibody drug conjugate or an antibody radionuclide conjugate to target the osteosarc...
Autores principales: | Westrøm, Sara, Bønsdorff, Tina B., Abbas, Nasir, Bruland, Øyvind S., Jonasdottir, Thora J., Mælandsmo, Gunhild M., Larsen, Roy H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077112/ https://www.ncbi.nlm.nih.gov/pubmed/27776176 http://dx.doi.org/10.1371/journal.pone.0165382 |
Ejemplares similares
-
Therapeutic Effect of α-Emitting (224)Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer()()
por: Westrøm, Sara, et al.
Publicado: (2018) -
Radon-220 diffusion from (224)Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
por: Napoli, Elisa, et al.
Publicado: (2021) -
Ra‐224 labeling of calcium carbonate microparticles for internal α‐therapy: Preparation, stability, and biodistribution in mice
por: Westrøm, Sara, et al.
Publicado: (2018) -
Experimental α-particle radioimmunotherapy of breast cancer using (227)Th-labeled p-benzyl-DOTA-trastuzumab
por: Abbas, Nasir, et al.
Publicado: (2011) -
HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors
por: Dailey, Deanna D, et al.
Publicado: (2013)